Blood marker study aims to predict preterm birth risk
NCT ID NCT01977079
First seen Nov 17, 2025 · Last updated Jun 18, 2026 · Updated 33 times
Summary
This study looked at whether a blood marker called procalcitonin can help predict which pregnant women hospitalized for threatened premature labor will actually deliver early. About 131 women participated, and researchers compared procalcitonin levels between those who gave birth before 37 weeks and those who did not. The goal was to improve prediction of preterm birth, but the study was terminated early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre hospitalier départemental Vendée
La Roche-sur-Yon, 85925, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.